BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2009
View Archived Issues
Mitsubishi Tanabe Pharma claims novel amine compounds for autoimmune diseases
Read More
New JAK inhibitors prepared and tested at Merck & Co.
Read More
Novel p38alpha MAPK inhibitors in development at Xcovery
Read More
Novel calcitonin gene-related peptide (CGRP) receptor antagonists disclosed by Merck & Co.
Read More
F2G claims novel antifungal agents
Read More
New cathepsin K inhibitors for treating osteoporosis imparted by AstraZeneca
Read More
EMEA grants Premacure orphan designation for Insmed's Iplex in infant ROP
Read More
Myriad acquires Panacos' HIV drug bevirimat
Read More
Neurologix initiates phase II clinical trial of gene transfer therapy for Parkinson's disease
Read More
Akesis discontinues sole clinical development program and files for bankruptcy
Read More
Phase III data support use of NGX-4010 in postherpetic neuralgia
Read More
Novartis launches Extavia for multiple sclerosis
Read More
Takeda initiates two phase III vedolizumab studies in inflammatory bowel disease
Read More
GSK's ofatumumab to be new clinical gold standard for CLL by 2012
Read More
Seattle and FDA reach agreement on SPA for trial of SGN-35 in Hodgkin lymphoma
Read More
BioDelivery and DNDi signed research and licensing agreement for Bioral Amphotericin B
Read More
Axikin, spin out of Actimis, reports funding for preclinical program
Read More
GlaxoSmithKline receives European approval to market orlistat 60 mg
Read More
ISTA reports positive phase IIb ecabet sodium trial results
Read More
Oncolys and Sysmex sign research agreement for circulating tumor cell diagnostic
Read More
The Leukemia & Lymphoma Society and Celator partner for CPX-351 in AML
Read More
Australian authorities approve Intercell's Japanese encephalitis vaccine
Read More
Gentium completes enrollment for the phase II/III European defibrotide trial
Read More
Stelara receives approval in Europe for moderate to severe plaque psoriasis
Read More